Authors:
Seijo, ER
Song, HJ
Lynch, MA
Jennings, R
Qong, X
Lazaridis, E
Muro-Cacho, C
Weghorst, CM
Munoz-Antonia, T
Citation: Er. Seijo et al., Identification of genetic alterations in the TGF beta type II receptor gene promoter, MUT RES-F M, 483(1-2), 2001, pp. 19-26
Authors:
Jennings, R
Alsarraj, M
Wright, KL
Munoz-Antonia, T
Citation: R. Jennings et al., Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites, ONCOGENE, 20(47), 2001, pp. 6899-6909
Citation: R. Battalio et al., The relationship among market-making revenue, payment for order flow, and trading costs for market orders, J FINAN SER, 19(1), 2001, pp. 39-56
Authors:
Levine, D
Jennings, R
Barnewolt, C
Mehta, T
Wilson, J
Wong, G
Citation: D. Levine et al., Progressive fetal bronchial obstruction caused by a bronchogenic cyst diagnosed using prenatal MR imaging, AM J ROENTG, 176(1), 2001, pp. 49-52
Authors:
O Foighil, D
Jennings, R
Park, JK
Merriwether, DA
Citation: D. O Foighil et al., Phylogenetic relationships of mid-oceanic ridge and continental lineages of Lasaea spp. (Mollusca : Bivalvia) in the northeastern Atlantic, MAR ECOL-PR, 213, 2001, pp. 165-175
Citation: Sa. Mohamedi et al., A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2ISCOMs in mice; cytokine profiles, antibody responses and protection, ANTIVIR RES, 49(2), 2001, pp. 83-99
Authors:
Mohamedi, SA
Brewer, JM
Alexander, J
Heath, AW
Jennings, R
Citation: Sa. Mohamedi et al., Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems, VACCINE, 18(20), 2000, pp. 2083-2094
Citation: Sa. Mohamedi et al., Therapeutic vaccination against HSV-2: influence of vaccine formulation onimmune responses and protection in mice, VACCINE, 18(17), 2000, pp. 1778-1792
Authors:
Grabowska, AM
Jennings, R
Laing, P
Darsley, M
Jameson, CL
Swift, L
Irving, WL
Citation: Am. Grabowska et al., Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2, VIROLOGY, 269(1), 2000, pp. 47-53
Authors:
Jones, JA
Hart, SF
Baskin, DS
Effenhauser, R
Johnson, SL
Novas, MA
Jennings, R
Davis, J
Citation: Ja. Jones et al., Human and behavioral factors contributing to spine-based neurological cockpit injuries in pilots of high-performance aircraft: Recommendations for management and prevention, MILIT MED, 165(1), 2000, pp. 6-12
Citation: Jr. Simms et al., Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection inn guinea pigs, J INFEC DIS, 181(4), 2000, pp. 1240-1248
Authors:
Zhang, Q
Choo, S
Everard, J
Jennings, R
Finn, A
Citation: Q. Zhang et al., Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents, INFEC IMMUN, 68(5), 2000, pp. 2692-2697
Authors:
Wigley, FM
Wise, R
Haythornthwaite, J
Rand, C
Smith, EA
Maricq, HR
Middaugh, S
Silver, RM
Valter, I
Allenback, G
Arnold, J
Steedman, S
Risinger, A
King, A
Bielory, L
Attanasio, V
Tarantola, J
Centeno, L
Jacob, RG
Medsger, T
Jennings, R
Scheier, M
Vaughan, C
Wasko, MC
Steen, VD
Dunbar-Jacob, J
Tamres, L
Freedman, RR
Mayes, MD
Brejnak, C
Tindall, C
Bielory, L
Thompson, B
Frederick, M
Canner, M
Canner, J
Canner, P
Shaffer, TR
Hill, DR
Kaufmann, PG
Czajkowski, S
Geller, N
Hunsberger, S
Jennings, C
Stevens, WM
Hess, EV
Corson, JA
Jobe, JB
Smith, H
Tilley, B
Citation: Fm. Wigley et al., Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up, ARCH IN MED, 160(8), 2000, pp. 1101-1108
Authors:
Jennings, R
Smith, TL
Myhren, F
Phillips, J
Sandvold, ML
Citation: R. Jennings et al., Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes, ANTIM AG CH, 43(1), 1999, pp. 53-61
Citation: R. Battalio et al., Order flow distribution, bid-ask spreads, and liquidity costs: Merrill Lynch's decision to cease routinely routing orders to regional stock exchanges, J FINANC IN, 7(4), 1998, pp. 338-358